Literature DB >> 17563070

Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis.

Sílvia Casas1, Ramon Gomis, Fiona M Gribble, Jordi Altirriba, Sakari Knuutila, Anna Novials.   

Abstract

OBJECTIVE: Human islet amyloid polypeptide (hIAPP) aggregation plays a major role in the development of islet amyloidosis in type 2 diabetes. It is known that extracellular hIAPP oligomers are toxic to pancreatic beta-cells and associated with apoptosis. We therefore investigated the molecular mechanism by which extracellular hIAPP mediates pancreatic beta-cell apoptosis. RESEARCH DESIGN AND METHODS: MIN6 cells and primary cultures of human pancreatic islets were treated with freshly dissolved hIAPP peptide. Morphology of the cultures was evaluated by electron microscopy. Gene expression was analyzed by microarray, RT-PCR, and immunoblot. Calcium levels were measured in fura-2-loaded cells. Apoptosis was quantified by cytometry.
RESULTS: Increased expression of several heat shock proteins and activation of the spliced form of XBP-1, a transcription factor for overexpression of chaperones during endoplasmic reticulum (ER) stress, were detected together with morphological evidence of ER dysfunction. Intracellular calcium overload was detected in association with this process. Moreover, reduction in the proteasome activity, which was detected over time, contributed to the intracellular accumulation of ubiquitinated proteins, leading to a functional suppression of the ubiquitin-proteasome pathway. In addition, impairment of the proteasome function contributed to apoptosis, while, despite the presence of hIAPP, cell viability improved when a proteasome activator was overexpressed. The key cytotoxic events induced by extracellular hIAPP were also observed in treated human islets.
CONCLUSIONS: Our data suggest that ER stress responses are intracellular signaling mechanisms induced by extracellular hIAPP aggregation and that impairment of the ubiquitin-proteasome pathway is implicated in ER stress-mediated pancreatic beta-cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563070      PMCID: PMC7217710          DOI: 10.2337/db07-0178

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  50 in total

1.  Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.

Authors:  Y Tanaka; S Engelender; S Igarashi; R K Rao; T Wanner; R E Tanzi; A Sawa; V L Dawson; T M Dawson; C A Ross
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

2.  Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.

Authors:  J Janson; W C Soeller; P C Roche; R T Nelson; A J Torchia; D K Kreutter; P C Butler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy.

Authors:  Pedro Filipe Teixeira; Filipe Cerca; Sofia D Santos; Maria João Saraiva
Journal:  J Biol Chem       Date:  2006-06-02       Impact factor: 5.157

Review 4.  Proteolysis: from the lysosome to ubiquitin and the proteasome.

Authors:  Aaron Ciechanover
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

5.  Protein quality control: chaperones culling corrupt conformations.

Authors:  Amie J McClellan; Stephen Tam; Daniel Kaganovich; Judith Frydman
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

6.  Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.

Authors:  P Westermark; U Engström; K H Johnson; G T Westermark; C Betsholtz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  A novel mutation in islet amyloid polypeptide (IAPP) gene promoter is associated with Type II diabetes mellitus.

Authors:  A Novials; I Rojas; R Casamitjana; E F Usac; R Gomis
Journal:  Diabetologia       Date:  2001-08       Impact factor: 10.122

8.  Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.

Authors:  S E Kahn; D A D'Alessio; M W Schwartz; W Y Fujimoto; J W Ensinck; G J Taborsky; D Porte
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

9.  Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity.

Authors:  Sungmin Song; So-Young Kim; Yeon-Mi Hong; Dong-Gyu Jo; Joo-Yong Lee; Sang Mi Shim; Chul-Woong Chung; Soo Jung Seo; Yung Joon Yoo; Jae-Young Koh; Min Chul Lee; Allan J Yates; Hidenori Ichijo; Yong-Keun Jung
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

Review 10.  Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.

Authors:  Rebecca L Hull; Gunilla T Westermark; Per Westermark; Steven E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

View more
  55 in total

1.  Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide.

Authors:  Mazin Magzoub; Andrew D Miranker
Journal:  FASEB J       Date:  2011-12-19       Impact factor: 5.191

2.  BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression.

Authors:  Gema Alcarraz-Vizán; Carlos Castaño; Montse Visa; Joel Montane; Joan-Marc Servitja; Anna Novials
Journal:  Cell Mol Life Sci       Date:  2017-03-23       Impact factor: 9.261

3.  A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo.

Authors:  Shubhangi Prabhudesai; Sharmistha Sinha; Aida Attar; Aswani Kotagiri; Arthur G Fitzmaurice; Rajeswari Lakshmanan; Ravi Lakshmanan; Magdalena I Ivanova; Joseph A Loo; Frank-Gerrit Klärner; Thomas Schrader; Mark Stahl; Gal Bitan; Jeff M Bronstein
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  Involvement of ATP-sensitive potassium (K(ATP)) channels in the loss of beta-cell function induced by human islet amyloid polypeptide.

Authors:  Maud Soty; Montse Visa; Sergi Soriano; María del Carmen Carmona; Ángel Nadal; Anna Novials
Journal:  J Biol Chem       Date:  2011-10-07       Impact factor: 5.157

5.  An inducible model of human amylin overexpression reveals diverse transcriptional changes.

Authors:  Yoseph Aldras; Sanghamitra Singh; Katrin Bode; Diti Chatterjee Bhowmick; Aleksandar Jeremic; Damien M O'Halloran
Journal:  Neurosci Lett       Date:  2019-04-08       Impact factor: 3.046

Review 6.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

7.  A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity.

Authors:  Jeffrey R Brender; Kevin Hartman; Kendra R Reid; Robert T Kennedy; Ayyalusamy Ramamoorthy
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

8.  Methylglyoxal alters the function and stability of critical components of the protein quality control.

Authors:  Carla Figueira Bento; Filipa Marques; Rosa Fernandes; Paulo Pereira
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

9.  Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress.

Authors:  R L Hull; S Zraika; J Udayasankar; K Aston-Mourney; S L Subramanian; S E Kahn
Journal:  Diabetologia       Date:  2009-04-08       Impact factor: 10.122

10.  Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach.

Authors:  Jordi Altirriba; Albert Barbera; Héctor Del Zotto; Belen Nadal; Sandra Piquer; Alex Sánchez-Pla; Juan J Gagliardino; Ramon Gomis
Journal:  BMC Genomics       Date:  2009-08-28       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.